Delivery Order SPE2DB20D1004-SPE2DB21FG1G1
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,238.13 firm fixed-price delivery order is for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, with a completion date of December 4, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,605.96 delivery order is for the supply of Albuterol HFA 90 MCG inhalers, with an ultimate completion date of November 15, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This single-award IDC...
- This federal contract award, valued at $1,178.52, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,560,362,344 units of the pharmaceutical product Albuterol HFA 90 MCG Inhaler 8.5 GM. The contract is a firm fixed-price delivery order with a completion date of March 24, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite...
- This federal contract award, valued at $1,337.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Albuterol HFA 90 MCG inhalers, a critical medication used in the treatment of respiratory conditions. The award is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. (doing business as Amerisourcebergen),...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,556,138,924 units of Albuterol HFA 90 MCG Inhaler 8.5GM. The $8,560.86 firm fixed-price delivery order was placed under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. (doing business as Amerisourcebergen) holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,918.53 firm fixed price delivery order is for the supply of 4567531714 Albuterol HFA 90 MCG Inhalers 8.5GM. The contract has an ultimate completion date of March 12, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,668.89, is a Firm Fixed Price Delivery Order for the supply of Albuterol HFA 90 MCG Inhalers. The contract has an ultimate completion date of February 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,120.20, is for the delivery of Albuterol HFA 90 MCG inhalers over the period ending on October 8, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
- This federal contract award is for the delivery of Albuterol HFA 90 MCG inhalers to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,066.78, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a delivery order contract with a firm fixed price pricing type, with a completion date of November 8, 2023. The contract is not designated with any set-aside requirements, indicating it was awarded through full and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,461.04, is a Firm Fixed Price Delivery Order for the supply of 4567342018 - ALBUTEROL HFA 90 MCG INHALER 8.5GM. The contract has an ultimate completion date of February 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB21FG1G1Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order valued at $6,493.59 for the procurement of Albuterol HFA 90 MCG inhalers. The contract has a completion date of September 24, 2021 and was awarded on a Firm Fixed Price basis with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 9/23/21 |